Esprit Scaffold Crosses Durability Hurdle in Below the Knee PAD

By News Health
1 hour Ago

(MedPage Today) — SAN FRANCISCO — Delivering on durability, the Esprit drug-eluting resorbable scaffold (DRS) maintained superior outcomes 3 years into the LIFE-BTK trial.
For infrapopliteal artery disease causing chronic limb-threatening…

Source link : https://www.medpagetoday.com/meetingcoverage/tct/118171

Author :

Publish date : 2025-10-27 20:26:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Being Fired From CDC Is Like Losing a Patient

Medicare to Spend $15B on Treatment Linked to Fraud, Patient Harm

More Trial Details Reported for Novel Psoriasis Pill

Start With Four-Food Elimination Diet for EoE, Researchers Say

Republicans Grapple With Voter Frustration Over Rising Healthcare Premiums

Hormone Therapy Linked to Autoimmune Disease in Women